Armephaco Joint Stock Company
Armephaco Joint Stock Company
🇻🇳 Vietnam, Hanoi
1998501-1000 peopleManufacturer/Trading Company/Wholesaler/Service CompanyArmephaco Joint Stock Company is a prominent Vietnamese manufacturer and service provider specializing in the pharmaceutical and medical equipment sectors. Established in 1996 and headquartered in Hanoi, the company transitioned from a state-owned entity under the Ministry of Defence to a Joint Stock Company. With a workforce of 501 to 1,000 employees and two dedicated production units, Armephaco operates as a manufacturer, wholesaler, and OEM provider. The company maintains rigorous quality standards, holding certifications for GMP-WHO, ISO 9001:2015, GLP (Good Laboratory Practice), and GSP (Good Storage Practice).
Their extensive product portfolio includes over 300 types of pharmaceuticals, ranging from neurological and anti-allergy medications to antimalarial treatments. In the medical equipment segment, they manufacture and supply multifunctional hospital beds, medical stainless steel instruments, and specialized medical gas pipeline systems. Beyond manufacturing, Armephaco provides comprehensive hospital construction services, medical warehousing, and logistics entrusted services.
The company's diverse business activities also encompass the wholesale of basic chemicals, electrical materials, telecommunication equipment, and industrial machinery. With six branches and multiple maintenance centers across Vietnam, Armephaco leverages its 28 years of experience to serve both domestic and international markets through the export of its manufactured medical and pharmaceutical products.
OEM manufacturerOffers OEM services for customized brand manufacturing.
High capacity factoryCan handle large-scale or bulk production orders.
Established brandFounded in 1998, with over 20 years of industry experience.
Multinational enterpriseOperates in multiple countries or regions like 🇻🇳 Vietnam, 🇰🇷 South Korea.
Contact
**************************
2
********************
1
Products
LOTUFAST
Cecopha 500
Mocovium M
Magnesi B6
STIMIND (PIRACETAM)
BRIKORIZIN
Giường đa chức năng một tay quay sắt sơn
Bàn tiêm – thay băng 2 tầng
Thiết bị rửa tay phòng mổ 2 vòi
Xe lăn tay Inox
Ghế xoay Inox 3 chân
Ghế phòng chờ 4 chỗ Inox
Customers
IMSIPHARMA
**********************
*******************
********************************
Unlock all 4 customers
Certifications
GMP2
ISO 90011
Ask AI about this supplier
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Pymepharco Joint Stock Company
🇻🇳 Vietnam
19891001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
668
Key customer
MERIEUX NUTRISCIENCES
Key market
🇻🇳 Vietnam
Description
Pymepharco Joint Stock Company is a leading pharmaceutical manufacturer and distributor based in Tuy Hoa, Vietnam. Established as a subsidiary of the global STADA Group, the company has evolved from a local medical supplier into a major regional player with a workforce of over 1,000 employees. Pymepharco specializes in the production of high-quality generic pharmaceuticals, prescription drugs, and OTC medicines, with a particular focus on antibiotics such as Cephalosporin. Their extensive product portfolio includes analgesics, antipyretics, anti-inflammatory drugs, vitamins, minerals, and dietary supplements, as well as medical equipment and medicinal chemicals.
The company operates advanced manufacturing facilities, including the modern PME II factory, which features a production capacity of 1.2 billion tablets per shift annually. Pymepharco is distinguished as a pioneer in Vietnam for achieving EU-GMP standards, ensuring their injectable powders, tablets, soft and hard capsules, and granules meet international quality benchmarks. In addition to its own branded products, the company provides OEM services and maintains strategic partnerships with international firms like Enzymatica. As a key contributor to the Southeast Asian pharmaceutical supply chain, Pymepharco focuses on delivering affordable, high-quality healthcare solutions through sustainable development and advanced scientific applications.
Pymepharco Building
Mekophar Chemical Pharmaceutical Joint-Stock Company
🇻🇳 Vietnam
1975501-1000 peopleManufacturer/Trading Company/DistributorHigh capacity factory
Established brand
Own brand
Industry association member
Shipments
84
Key customer
NIPRO
Key market
🇻🇳 Vietnam
Description
Mekophar Chemical Pharmaceutical Joint-Stock Company (MEKOPHAR) is a prominent Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. Established in 1975 and equitized as a joint-stock company in 2002, the organization has grown into a major industry player with a workforce of approximately 500 to 1,000 employees and an annual revenue estimated at $157.9 million. The company operates multiple production bases and a nationwide distribution network with branches in Hanoi, Da Nang, and Can Tho.
Mekophar specializes in a comprehensive range of healthcare solutions, including the manufacturing, export, and import of pharmaceuticals, herbal medicines, and oriental medicines. Its extensive product portfolio covers therapeutic areas such as antibiotics (oral and injectable), analgesics, antipyretics, cardiovascular drugs, gastrointestinal agents, and antimalarials. Beyond finished dosage forms, the company supplies pharmaceutical raw materials, medical devices, and specialized packaging solutions including plastic bottles and carton boxes.
As a vertically integrated manufacturer, Mekophar offers OEM services and maintains a focus on high-quality standards to serve both domestic and international markets. The company has also diversified its business interests into stem cell banking services through its relationship with Mekostem, as well as food technology and cosmetics. Listed on the UPCOM securities trading center under the ticker MKP, Mekophar remains a key contributor to the regional pharmaceutical sector through its commitment to safe and effective public health products.
Mekophar company building
Mekophar Logo
Mekophar Building
pharmaceuticals
